Another month, another tumor board talk. The slides aren’t self-sufficient, I’m afraid, but the references might be a good starting point for learning more about TCHRLBCL1, or diffuse large B-cell lymphoma in general. I’d start with this excellent review article on DLBCL treatment, written by several NCI attendings2.

The final two slides, after the thank-you slide, are there just in case. I try to time the 30-minute talk to 20 minutes, counting on audience participation. If that fails and there is some time left over, I have a back-up.

Error: Embedded data could not be displayed.

You can see a full-screen version of the presentation here.


  1. WTF 

  2. All of whom are—and please excuse the overused word—awesome.